Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Altace (ramipril) Capsules, 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-035 7/10/02 7/15/02 Altace (ramipril) Capsules, 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-034 8/2/02 8/6/02 Altace (ramipril) Capsules,1.25, 2.5, 5, & 10 mg Hoechst Marion Roussel, NDA 19-901/S-025 12/16/98 3/13/00 Altace (ramipril) Capsules , 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-028 10/4/00 Altace Indication: Reduction in risk of myocardial infarction, stroke, and death from cardiovascular causes RAMIPRIL Capsule; 1.25MG ALTACE KING 019901 RAMIPRIL Capsule; 10MG ALTACE KING 019901 RAMIPRIL Capsule; 2.5MG ALTACE KING 019901 RAMIPRIL Capsule; 5MG ALTACE KING | Altace (ramipril) Capsules, King Pharma, Labeling Revision | Altace (ramipril) Capsules, King Pharmaceuticals, Labeling Revision | Ramipril Capsules, Roxane Labs, Tentative Approval | Ramipril Capsules, Sandoz Inc., Tentative Approval | Ramipril Capsules, Teva Pharma, Tentative Approval | Ramipril Capsules, Dr. Reddy’s Labs, Tentative Approval | Ramipril Capsules, Dr. Reddy’s Labs, Tentative Approval | Ramipril Capsules, InvaGen Pharma, Tentative Approval | Ramipril Capsules, Lupin Pharmaceuticals, Inc., Tentative Approval | Ramipril Capsules, Lupin Pharmaceuticals, Inc., Approval | Ramipril Capsules, Actavis Mid Atlantic, LLC, Approval | Ramipril Capsules, Sandoz Inc., Approval | Ramipril Capsules, Roxane Laboratories, Inc., Approval | Ramipril Capsules, Invagen Pharmaceuticals, Inc., Approval | Ramipril Capsules, Teva Pharmaceuticals USA, Approval | Ramipril Capsules, Dr. Reddy's Laboratories, Ltd., Approval | Agrylin (anagrelide hydrochloride) Capsules, Shire Development, Inc., Labeling Revision | Ramipril Capsules, Dr. Reddy's Labs, Ltd., Approval | Ramipril Capsules, Apotex Corp., Approval | Ramipril Capsules, Cipla Ltd, Approval | Ramipril Capsules, Zydus Pharmaceuticals USA Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com